- Home
- GT vs CLDX Comparison
GT vs CLDX Comparison
Compare GT & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GT
- CLDX
- Stock Information
- Founded
- GT 1898
- CLDX N/A
- Country
- GT United States
- CLDX United States
- Employees
- GT N/A
- CLDX N/A
- Industry
- GT Automotive Aftermarket
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GT Consumer Discretionary
- CLDX Health Care
- Exchange
- GT Nasdaq
- CLDX Nasdaq
- Market Cap
- GT 2.0B
- CLDX 1.9B
- IPO Year
- GT N/A
- CLDX 2008
- Fundamental
- Price
- GT $7.58
- CLDX $22.93
- Analyst Decision
- GT Buy
- CLDX Buy
- Analyst Count
- GT 4
- CLDX 10
- Target Price
- GT $11.38
- CLDX $44.20
- AVG Volume (30 Days)
- GT 9.3M
- CLDX 845.3K
- Earning Date
- GT 11-03-2025
- CLDX 11-03-2025
- Dividend Yield
- GT N/A
- CLDX N/A
- EPS Growth
- GT N/A
- CLDX N/A
- EPS
- GT N/A
- CLDX N/A
- Revenue
- GT $18,310,000,000.00
- CLDX $5,790,000.00
- Revenue This Year
- GT N/A
- CLDX N/A
- Revenue Next Year
- GT $0.63
- CLDX N/A
- P/E Ratio
- GT N/A
- CLDX N/A
- Revenue Growth
- GT N/A
- CLDX N/A
- 52 Week Low
- GT $6.51
- CLDX $14.40
- 52 Week High
- GT $12.03
- CLDX $29.05
- Technical
- Relative Strength Index (RSI)
- GT 54.55
- CLDX 34.74
- Support Level
- GT $6.76
- CLDX $25.70
- Resistance Level
- GT $8.16
- CLDX $26.85
- Average True Range (ATR)
- GT 0.27
- CLDX 1.09
- MACD
- GT 0.13
- CLDX -0.54
- Stochastic Oscillator
- GT 58.21
- CLDX 6.91
About GT The Goodyear Tire & Rubber Company
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.